```html

Theileria Infection – Comprehensive Medical Guide

Overview

Theileria is a genus of intra‑cellular protozoan parasites that infect a wide range of mammals, most notably cattle, sheep, goats, and wildlife. In humans, infection is rare but has been reported in several tropical and subtropical regions where the tick vectors are endemic. The disease caused by Theileria species is called theileriosis or “theilerial fever.”

• Primary hosts: Cattle (e.g., T. parva, T. annulata), small ruminants, wild ungulates.
• Human cases: Documented mainly in Africa and parts of Asia; prevalence in humans is < 0.1 % in endemic areas, but the exact number is uncertain because many infections are asymptomatic.
• Geographic distribution: Sub‑Saharan Africa, India, the Middle East, and the Mediterranean basin. The highest burden in cattle occurs in East Africa where East Coast fever (T. parva) kills up to 70 % of susceptible calves if untreated (FAO, 2022).

Although most information and public health focus are on veterinary theileriosis, clinicians should be aware of its zoonotic potential, especially for people with frequent tick exposure (farm workers, hunters, veterinarians).

Symptoms

Symptoms vary by Theileria species, host, and disease stage. In humans the illness is usually milder than in cattle, but it can still be severe.

Acute Phase (1–10 days after tick bite)

• Fever: High‑grade (≥38.5 °C) often intermittent.
• Headache and muscle aches (myalgia).
• Fatigue and generalized weakness.
• Chills and rigors.
• Gastrointestinal upset: Nausea, vomiting, abdominal pain, occasional diarrhea.
• Skin rash: Rare, may appear as maculopapular lesions.

Hematologic / Systemic Manifestations

• Hemolytic anemia: Pale skin, shortness of breath.
• Thrombocytopenia: Easy bruising or petechiae.
• Leukopenia: Increased susceptibility to secondary infections.

Severe / Complicated Forms

• Neurologic signs: Confusion, seizures, coma (rare, usually with T. parva in immunocompromised).
• Renal insufficiency: Decreased urine output, dark urine.
• Hepatomegaly & elevated liver enzymes.
• Respiratory distress: Rapid breathing, hypoxia.

Causes and Risk Factors

Etiology

Theileria parasites are transmitted primarily by ixodid (hard) ticks. The life cycle includes:

1. Infected tick salivates parasites into the host’s bloodstream while feeding.
2. Parasites invade lymphocytes (or erythrocytes, depending on species) and multiply.
3. Infected cells circulate, allowing the parasite to spread.
4. Ticks ingest parasites during subsequent blood meals, completing the cycle.

Key Species That Infect Humans

• Theileria orientalis – reported in Japan and China.
• Theileria buffeli – occasional cases in Africa.
• Experimental infections with T. parva have been documented in laboratory workers.

Risk Factors

• Living or working in tick‑endemic rural areas.
• Occupations with high tick exposure: farmers, veterinarians, wildlife researchers.
• Travel to endemic regions without proper tick protection.
• Immunosuppression (HIV, chemotherapy, organ transplant) – increases likelihood of severe disease.
• History of livestock ownership; close contact with infected animals raises exposure risk.

Diagnosis

Accurate diagnosis combines clinical suspicion with laboratory confirmation.

Laboratory Tests

• Peripheral blood smear: Giemsa‑stained smear may reveal intra‑cellular piroplasms inside erythrocytes or schizonts in lymphocytes. Sensitivity ~60 % in early infection.
• Polymerase Chain Reaction (PCR): Species‑specific PCR is the gold standard, detecting low‑level parasitemia (<1 parasite/µL). Sensitivity > 95 %.
• Serology: Indirect fluorescent antibody test (IFAT) or ELISA for IgG/IgM antibodies. Useful for epidemiologic surveys; may remain positive months after clearance.
• Complete blood count (CBC): Often shows anemia, thrombocytopenia, leukopenia.
• Biochemistry panel: Elevated liver enzymes (AST, ALT), bilirubin, and creatinine in severe cases.

Imaging (if complications suspected)

• Chest X‑ray or CT for pulmonary infiltrates.
• Renal ultrasound if renal failure develops.

Diagnostic Criteria (per CDC/WHO)

1. History of tick exposure in an endemic area.
2. Compatible clinical syndrome (fever ± hematologic abnormalities).
3. Laboratory confirmation (PCR or identified parasites on smear).

Treatment Options

Prompt anti‑protozoal therapy shortens disease duration and reduces complications.

First‑Line Medications

• Buparvaquone (100 mg/m² IV once daily for 5–7 days) – the drug of choice for severe bovine theileriosis and has shown efficacy in human cases (clinical case series, 2021).
• Diminazene aceturate (3 mg/kg IM or IV daily for 3 days) – used where buparvaquone unavailable; monitor for nephrotoxicity.
• Imidocarb dipropionate (0.5 mg/kg IM) – effective against T. orientalis, especially when anemia is prominent.

Adjunctive Therapies

• Supportive care: antipyretics (acetaminophen), IV fluids, blood transfusion for severe anemia.
• Broad‑spectrum antibiotics only if bacterial superinfection is suspected.
• Electrolyte replacement and renal monitoring for drug‑induced nephrotoxicity.

Special Situations

• Pregnancy: Buparvaquone is Category C; weigh maternal benefits against fetal risk. Close obstetric monitoring required.
• Renal/hepatic impairment: Dose‑adjust buparvaquone and avoid imidocarb.

Resistance & Emerging Therapies

Isolates with decreased sensitivity to buparvaquone have been reported in East Africa (FAO, 2023). Ongoing trials are evaluating atovaquone‑proguanil and novel molecular inhibitors, but these remain experimental.

Living with Theileria Infection

Most patients recover fully with treatment, but some experience prolonged fatigue or mild anemia.

Daily Management Tips

• Complete the full prescribed medication course—even if you feel better.
• Stay well‑hydrated; aim for 2–3 L of fluid daily unless restricted by a physician.
• Monitor temperature twice daily; keep a log for your clinician.
• Eat a balanced diet rich in iron (lean meats, legumes, leafy greens) to aid recovery from anemia.
• Limit alcohol and avoid NSAIDs if you have renal involvement.
• Schedule follow‑up blood work (CBC, liver/kidney panel) 1‑2 weeks after treatment to confirm clearance.

Psychosocial Support

Living in a tick‑endemic area can cause anxiety. Consider joining local farmer or veterinary health groups for shared prevention strategies and emotional support.

Prevention

Because the parasite is tick‑borne, reducing tick exposure is the cornerstone of prevention.

• Protective clothing: Long sleeves, long trousers, and closed shoes when in fields or woodlands.
• Tick repellents: Apply 20–30 % DEET, picaridin, or IR3535 to skin and clothing; reapply per label.
• Environmental control: Keep grass short, clear brush around homes and animal shelters, and treat livestock with acaricides (e.g., permethrin, amitraz).
• Personal tick checks: Conduct thorough examinations daily; remove attached ticks promptly with fine‑tip tweezers.
• Vaccination (livestock): Live attenuated vaccine against T. parva (Infection and Treatment Method, ITM) is widely used in East Africa, reducing herd incidence by >80 % (FAO, 2022).
• Travel advice: For tourists, avoid hiking during peak tick activity (early morning/evening), and consider prophylactic acaricide‑treated clothing.

Complications

If untreated or inadequately treated, Theileria infection can progress to serious, sometimes life‑threatening conditions.

• Severe hemolytic anemia – may require multiple blood transfusions.
• Acute kidney injury – secondary to hemoglobinuria and dehydration.
• Respiratory failure – from pulmonary edema or secondary bacterial pneumonia.
• Neurological sequelae – encephalitis, lasting cognitive deficits (rare).
• Coagulopathy – disseminated intravascular coagulation (DIC) in fulminant cases.
• Chronic carrier state – low‑level parasitemia persisting for months, potentially leading to relapse during immunosuppression.

When to Seek Emergency Care

---

Sources: Mayo Clinic, CDC, WHO, NIH (NCBI), FAO Theileriosis Technical Manual (2022), Cleveland Clinic Infectious Disease Guidelines, Journal of Clinical Microbiology (2021), Veterinary Parasitology (2023).

```